Serum Institute of India commenced with a humble beginning of Tetanus Antitoxin and has now emerged as the world’s largest manufacturer of Measles Vaccine and DTP group of vaccines, with the result that at least one of two children born has been administered with Measles vaccine or DTP vaccine manufactured by Serum Institute.

Serum Institute went on to launch, Polyvalent Anti-Snake Venom Serum, Measles Vaccine on Human Diploid Cells, Measles, Mumps and Rubella Virus Vaccine, Polyvalent Anti-Snake Venom Serum (Central Africa), Mumps Virus Vaccine, Measles and Mumps Virus Vaccine, Measles and Rubella Virus Vaccine and several other products that attest to its seriousness of purpose.
Some of the products in the pipeline are Hepatitis B Vaccine, Hepatitis B-DTP Combination Vaccine, BCG Vaccine, Rabies Vaccine (Human Diploid Cells) and Rotavirus Vaccine.

Serum Institute made it an unstated policy to secure and retain only the best in terms of human resources, in terms of equipment and technology, in terms of materials and consumables. It established a proud record of ‘Innovation without limits’ and ‘Quality without compromise’.

Progressively, Serum Institute eliminated India’s dependence on imports for several product lines

  • emerged as the largest supplier for the Government’s Expanded Programme of Immunization.
  • brought the latest research and manufacturing technologies to the country, and simultaneously scored in developing indigenous processes.
  • nurtured a core group of Biotechnology scientists, which has gained official recognition in International scientific forums and is the only private sector manufacturer of vaccines from a developing nation to be invited to Geneva for WHO’s programme of ‘Children’s Vaccine Initiative’.

Serum Institute of India is basically an organisation concentrating on vaccines and other biologicals. The need was felt for introducing pharmaceuticals like Haematinics, Calcium Supplements, Digestives, Anti-diarrhoeals, Hormones, etc..

  
  
  
 
Launch of Penta Vaccine
Launch of DTP-HB-HIB Vaccine
Launched indigenously developed DTP-HB Combination vaccine, SII Q-VAC.
Launched the World's only adsorbed liquid HDC Rabies vaccine, SII RABIVAX.

Launch of BCG vaccine.
Launch of indigenously manufactured Recombinant Hepatitis-B vaccine 'GeneVac-B'.
One out of every two children in the world vaccinated by Serum Institute’s vaccine.
Serum Institute recognised as the largest producer of Measles and DTP vaccines in the world.
Export of vaccines crossed over to 100 countries.
Commencement of export of Anti-cancer products.
Use of Modular Laboratory meeting international GMP requirements.

Use of Automatic printing and Labelling Machine, use of Automatic Inspection Machine (screening) for liquids in ampoules and vials.
Commencement of export of vaccines to UN agencies.
Manufacture of MMR Vaccine and MR vaccine for the first time in India.
Launch of Serum International Limited.
Manufacture of Rubella virus vaccine (monovalent Rubella vaccine) for the first time in India.
Anti-snake Venom Serum, incorporating venoms from snakes in Central African Countries introduced.
Manufacture of M-Vac (Measles Vaccine) using E-Z Strain of virus on Human Diploid Cells for the first time in India.
Product availability expanded to include range of Fertility Products of World Leaders, Serono of Switzerland.
The film 'Snakebite' awarded ‘Best Professional Film Award’ at ninth International Film Festival in U.S.A. Followed by two more international awards in 1987 and 1989.
Technological breakthrough results in first-time-ever manufacture of Quadruple Vaccine (DTP with Inactivated Polio Vaccine).
Hi-tech plant set up for large-scale manufacture of Human Albumin from human placenta.
 
A 2500- litre Blending Vessel, largest in the world for DTP vaccine, successfully fabricated and commissioned.
 
Landmark visit, for technical conference, by Dr. Jonas Salk of Salk’s Polio Vaccine fame.
Introduction of Anti-D Rho Immunoglobulin, Iyophilised and tested on Autoanalyser.
Manufacturing of life-saving Polyvalent Anti-Snake Venom Serum effective against four poisonous snakes commonly encountered in India commenced.
First-time-in the-world collection of equine serum by simultaneous and continuous plasmapheresis using IBM Computerised Cell Separator.
In response to urgent requirement of vaccines for India’s EPI, giant Blending Vessels indigenously fabricated.
Autonomous scientific wing, Serum Institute of India Research Foundation established.
Triple Antigen (Diphtheria-Tetanus-Pertussis) Vaccine production commenced.
Large-scale manufacture of Adsorbed Tetanus Toxoid undertaken.
Operations started with manufacture of Tetanus Antitoxin followed by Fluid Tetanus Toxoid.  

Copyright © 2007 Serum Institute of India Limited. Legal Disclaimer.